FFCP PHASE2:Hg19::chr17:56356444..56356472,+
From FANTOM5_SSTAR
Revision as of 19:15, 25 July 2015 by Autoedit (talk | contribs) (Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=NA |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript |HGNC=NA |TSSclassifier=stron...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
| Short description: | p@chr17:56356444..56356472, + |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chr17:56356444..56356472, + |
| Coexpression cluster: | C209_acute_myelodysplastic_CD34_granulocyte_CD133_liver_spleen |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p@chr17:56356444..56356472+ |
|---|
0
5
10
15
20
25
30
35
40
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| syndrome | 4.61e-26 | 1 |
| myeloid leukemia | 3.29e-20 | 31 |
| leukemia | 3.90e-16 | 39 |
| hematopoietic system disease | 9.40e-14 | 2 |
| hematologic cancer | 2.08e-12 | 51 |
| immune system cancer | 2.08e-12 | 51 |
| cardiovascular system disease | 1.59e-07 | 4 |
Showing 1 to 7 of 7 entries
